Abstract
Purpose
To report about the outcome of radiation treatment of advanced lung cancer patients with volumetric modulated arcs [RapidArc (RA)].
Patients and methods
Seventy-five consecutive patients (all stages IIIA and IIIB) were treated with RA. Among them 71 % were men; 25.4 % presented unspecified non-small cell lung cancer, 41.3% adenocarcinoma and 33.3 % squamous cell carcinoma. Of them, 54.7 % received sequential chemotherapy while 45.3% were treated with concomitant regimen. Dose prescription ranged from 54 to 72 Gy. Analysis included survival, local control (LC) and toxicity profiles.
Results
Median follow-up was 21.2 months (range 6–75). One- two- and five-year actuarial LC was 91.9 ± 3.2, 79.5 ± 5.7 and 67.4 ± 9.5 %, respectively. Median survival was 19.0 ± 1.1 months. Actuarial survival at 1–2–5 years was 80.0 ± 4.6, 38.5 ± 5.9 and 15.2 ± 4.9 %, respectively. Acute toxicity of G2 was reported in 24, 25.3 and 4.0 % of patients for lung, esophageal and hematological profiles. A total of 2.7 % of patients reported G3 toxicity in the esophagus and 5.3 % of the patients experienced G3–G4 hematological toxicity. Significant differences were observed in all cases between concomitant and sequential chemotherapy regiments. Only 1.3 % (1 patient) showed G2 lung late toxicity. No significant correlation was found between toxicity and organ’s irradiation levels.
Conclusion
RA proved to be a safe and advantageous treatment modality for advanced lung cancer with results in line with expectations from earlier literature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bignardi M, Cozzi L, Fogliata A, Lattuada P, Mancosu P, Navarria P, Urso G, Vigorito S, Scorsetti M (2009) Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes. Int J Radiat Oncol Biol Phys 75:1570–1577
Bradley J, Paulus R, Komaki R et al (2013) A randomized phase III comparison of standard dose (60 Gy) versus high dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: results on radiation dose in RTOG 0617. J Clin Oncol 31:7501
Chen C, Uyterlinde W, Sonke J, de Bois J, van den Heuvel M, Belderbos J (2013) Severe late esophagous toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy. Radiother Oncol 108:337–341
Christodoulou M, Bayman N, McCloskey P, Rowbottom C, Faivre-Finn C (2015) New radiotherapy approaches in locally advanced non small cell lung cancer. Eur J Cancer 50:525–534
Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, Jamema SV, Vanetti E, Clivio A, Nicolini G, Fogliata A (2008) A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89:180–191
Curran WJ, Scott CB, Langer CJ et al (2003) Long term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresectable stage III NSCLC: RTOG 94-10. Proc Am Soc Clin Oncol 22:621a (abstr 2499)
Dilmann RO, Seagren SL, Propert KJ et al (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Eng J Med 323:940–945
Fogliata A, Clivio A, Nicolini G, Vanetti E, Cozzi L (2008) Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol 89:254–262
Graham MV, Purdy J, Emami B, Matthews J, Hamrs W (1995) Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 31:819–825
Harris J, Murphy J, Hanlon A, Le Q, Loo B, Diehn M (2014) A population based comparative effectiveness study of radiation therapy techniques in stage III non small cell lung cancer. Int J Radiat Oncol Biol Phys 88:872–884
Hayman JA, Martel MK, Ten Haken RK, Normolle DP, Todd RF 3rd, Littles JF, Sullivan MA, Possert PW, Turrisi AT, Lichter AS (2001) Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 19(1):127–136
Jamal A, Twari RC, Murray T et al (2004) Cancer statistic. CAJ Clin 54(8):29
Kjær-Kristoffersen F, Ohlhues L, Medin J, Korreman S (2009) RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol 48:227–232
Kwa SL, Lebesque JV, Theuws JC, Marks L, Munley M, Bentel G, Oetzel D, Spahn U, Graham M, Drzymala R, Purdy J, Lichter A, Martel M, Ten Haken R (1998) Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42:1–9
Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier M, Douillard J, Laplanche A (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417–423
Leprieur E, Fernandez D, Chatellier G, Klotz S, Giraud P, Durdux C (2013) Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: clinical, dosimetric and associated treatment risk factors. J Cancer Res Ther 9:447–451
Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens C, Guerrero T, Komaki R, Cox J, Mohan R (2004) Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1268–1279
Mancosu P, Navarria P, Bignardi M, Cozzi L, Fogliata A, Lattuada P, Santoro A, Urso G, Vigorito S, Scorsetti M (2010) Re-irradiation of metastatic spinal cord compression: a feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal. Radiother Oncol 94:67–70
Navarria P, Ascolese AM, Mancosu P, Alongi F, Clerici E, Tozzi A, Iftode C et al (2013) Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC). Radiother Oncol 107:414–418
Ong CL, Verbakel WF, Dahele M, Cuijpers JP, Slotman BJ, Senan S (2012) Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors. Int J Radiat Oncol Biol Phys 83:e137–e143
Palma D, Senan S, Oberije C, Belderbos J, de Dios N, Bradley J, Barriger R, Moreno Jimenez M, Kim T, Ramella S, Everitt S, Rengan R, Marks L, De Ruyck K, Warner A, Rodrigues G (2013) Predicting esophagitis after chemoradiation therapy for non small cell lung cáncer: an individual patient data meta analysis. Int J Radiat Oncol Biol Phys 87:690–696
Rengan R, Rosenzweig KE, Venkatraman E, Koutcher L, Fox J, Navak R, Amols H, Yorke E, Jackson A, Ling C, Leibel S (2004) Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60:741–747
Rosenzweig KE, Fox JL, Yorke E, Amols H, Jackson A, Rusch V, Kris M, Ling CC, Leibel S (2005) Results of phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non small cell lung carcinoma. Cancer 103:2118–2127
Sause W, Kolesar P, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Byhardt R, Dar A, Turrisi A (2000) Final results of phase III trial in regionally advanced unresectable non small cell lung cancer. Chest 117:358–364
Scorsetti M, Bignardi M, Clivio A, Cozzi L, Fogliata A, Lattuada P, Mancosu P, Navarria P, Nicolini G, Urso G, Vanetti E, Vogorito S, Santoro A (2010a) Volumetric modulation arc radiotherapy compared with static gantry IMRT for malignant pleural mesothelioma tumour: a feasibility study. Int J Radiat Oncol Biol Phys 77:942–949
Scorsetti M, Navarria P, Mancosu P, Alongi F, Castiglioni S, Cavina R, Cozzi L et al (2010b) Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc. Radiat Oncol 5:94
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan R, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom A, Christian M, Gwyther S (2000) New guidelines to evaluate the response to treatment in solid tumor. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United State, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216
Verbakel W, Cuijpers J, Hoffmans D, Bieker M, Slotman B (2009a) Volumetric intensity modulated arc therapy versus conventional IMRT in head and neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys 74:252–259
Verbakel WF, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ (2009b) Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 93:122–124
Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks L (2010) Radiation dose volume effects in the esophagus. Int J Radiat Oncol Biol Phys 76:S86–S93
Weyh A, Konski A, Nalichowski A, Maier J, Lack D (2013) Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMRT. J Appl Clin Med Phys 14:4065
Conflict of interest
L. Cozzi acts as Scientific Advisor to Varian Medical Systems and is Head of Research and Technological Development to IOSI, Bellinzona. All other coauthors have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scorsetti, M., Navarria, P., De Rose, F. et al. Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. J Cancer Res Clin Oncol 140, 1937–1945 (2014). https://doi.org/10.1007/s00432-014-1739-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-014-1739-7